TENS Used for Pain Management During Office Cystoscopy Botox Injections
NCT04448171 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2025-08-20
Summary
The purpose of this study is to determine how Transcutaneous Electric Nerve Stimulation (TENS) units affects pain management during office cystoscopic Botox injections and patient satisfaction with the procedure .
Conditions
Interventions
- DEVICE
-
Active TENS
Standard TENS unit with four pads affixed to the lower back area, will be used in this arm. The TENS device will be set to an active setting.
- DEVICE
-
Sham TENS
Standard TENS unit with four pads affixed to the lower back area, will be used in this arm. The TENS device will be set to an inactive setting.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
John A Occhino, MD, MS · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-28
- Primary Completion
- 2023-10-31
- Completion
- 2023-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection
NCT03508921 ·Status: TERMINATED ·Phase: PHASE4
-
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
NCT05308979 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Trial for Botox Urinary Incontinence
NCT00178191 ·Status: COMPLETED ·Phase: NA
-
Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study
NCT03385460 ·Status: UNKNOWN ·Phase: NA
-
Procedural Discomfort Related to Number of Intradetrusor Botox Injections
NCT05652036 ·Status: COMPLETED ·Phase: PHASE4
-
PTNS vs Botox of Refractory OAB
NCT04451382 ·Status: TERMINATED
-
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)
NCT02097121 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients
NCT02179099 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Over Active Bladder Instillation Study - Botox
NCT00667095 ·Status: TERMINATED ·Phase: PHASE3
-
BOTOX® at the Time of Prolapse Surgery for OAB
NCT04807920 ·Status: UNKNOWN ·Phase: PHASE4
-
Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
NCT01220726 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin Type A for Neuroma Pain
NCT01374191 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)
NCT02786407 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparative Study Suburothelial and Trigonal Botulinum Toxin A Injection in Treatment of Interstitial Cystitis
NCT03076762 ·Status: UNKNOWN ·Phase: PHASE2
-
BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence
NCT03320850 ·Status: COMPLETED ·Phase: PHASE2
-
Botox as a Treatment for Interstitial Cystitis in Women
NCT00194610 ·Status: COMPLETED ·Phase: PHASE4
-
Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)
NCT02735499 ·Status: COMPLETED ·Phase: PHASE2
-
Intravesicular Onabotulinumtoxin A in Interstitial Cystitis
NCT02297100 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Efficacy and Patient Satisfaction of Local Anaesthesia Versus Sedoanalgesia for Botox (R) Injection in the Urinary Bladder for the Treatment of Idiopathic Overactive Bladder
NCT06437899 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
NCT01852045 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain
NCT00404417 ·Status: UNKNOWN ·Phase: PHASE4
-
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
NCT05463822 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00461292 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients
NCT01997983 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain
NCT01905137 ·Status: UNKNOWN ·Phase: NA